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Abstract
Background: Recent reports suggest an association between unexplained chronic cough and obstructive sleep apnea 
(OSA). Current guidelines provide an empiric integrative approach to the management of chronic cough, particularly 
for etiologies of gastroesophageal reflux (GERD), upper airway cough syndrome (UACS) and cough variant asthma 
(CVA) but do not provide any recommendations regarding testing for OSA. This study was done to evaluate the 
prevalence of OSA in patients referred for chronic cough and examine the impact of treating OSA in resolution of 
chronic cough.
Methods: A retrospective review of chronic cough patients seen over a four-year period in a community-based 
pulmonary practice was done. Patients with abnormal chest radiographs, abnormal pulmonary function tests, history 
of known parenchymal lung disease, and inadequate followup were excluded. Clinical data, treatments provided and 
degree of resolution of cough was evaluated based on chart review. Specifically, diagnostic testing for OSA and impact 
of management of OSA on chronic cough was assessed.
Results: 75 patients with isolated chronic cough were identified. 44/75 had single etiologies for cough (GERD 37%, 
UACS 12%, CVA 8%). 31/75 had multiple etiologies for their chronic cough (GERD-UACS 31%, GERD-CVA 5%, UACS-CVA 
3%, GERD-UACS-CVA 3%). 31% patients underwent further diagnostic testing to evaluate for UACS, GERD and CVA. 
Specific testing for OSA was carried out in 38/75 (51%) patients and 33/75 (44%) were found to have obstructive sleep 
apnea. 93% of the patients that had interventions to optimize their sleep-disordered breathing had improvement in 
their cough.
Conclusions: OSA is a common finding in patients with chronic cough, even when another cause of cough has been 
identified. CPAP therapy in combination with other specific therapy for cough leads to a reduction in cough severity. 
Sleep apnea evaluation and therapy needs to considered early during the management of chronic cough and as a part 
of the diagnostic workup for chronic cough.
Background
The revised ACCP guidelines provide a step-wise
approach for managing patients with chronic cough [1].
These guidelines recommend basing the etiology of
chronic cough upon clinical opinions derived from his-
torical information and therapeutic interventions [1].
Considerable variations therefore result in the manage-
ment of chronic cough. Variations in management also
stem from the diagnostic workup used to ascertain the
cause of cough [2] and also from the occurrences of mul-
tiple etiologies of chronic cough [3]. Recent reports have
suggested an association between chronic cough and
obstructive sleep apnea (OSA) [4]. There is also evidence
that treatment of sleep apnea can improve chronic cough
[5]. Despite the lack of any specific guidelines on testing
for OSA in patients with chronic cough [6,7], the impact
of treatment of OSA is being noted in community-based
pulmonary practices where chronic cough is most fre-
quently encountered.
This study was undertaken to evaluate current strate-
gies in approaches to chronic cough in non-smokers
without known parenchymal lung disease in a large com-
munity-based pulmonary clinic. Besides evaluating treat-
ment regimens and diagnostic testing, the impact of
diagnosis and treatment of sleep apnea on the course of
chronic cough was also assessed.
* Correspondence: krishna.sundar@imail.org
1 Intermountain Utah Valley Pulmonary Clinic, 1055N, 300W, Provo, UT 84604, 
USA
Full list of author information is available at the end of the articleSundar et al. Cough 2010, 6:2
http://www.coughjournal.com/content/6/1/2
Page 2 of 7
Methods
A retrospective review of medical records of patients
seen in the Utah Valley Pulmonary Clinics in Provo and
American Fork between 2005 and 2009 was done. Charts
with diagnoses of "cough" and "bronchitis" were reviewed
for cough lasting longer than 8 weeks. Since this study
was confined to the evaluation of chronic cough in non-
smokers without parenchymal lung disease, patients with
abnormal chest X-rays, any prior smoking history, history
of asthma requiring maintenance therapy, history of
chronic parenchymal lung disease were excluded. Also
patients that were not compliant with follow-up visits
were excluded. Patients with only "normal" spirometry
were included. Pulmonary function tests were conducted
and interpreted based on the Intermountain Thoracic
Society standards [8].
Following above exclusions, 75 patient records were
identified and reviewed for clinical data, diagnostic
workup and therapeutic interventions. Clinical data
obtained included demographic information, cough
duration, comorbidities, etiologies for chronic cough,
treatments provided and ancillary laboratory, radiologi-
cal, and physiological workup. Patient records were spe-
cifically reviewed for mention of details regarding
concomitant or pre-existing evaluation for OSA. Details
regarding sleep history, physical exam pertinent to sleep
apnea (pharyngeal crowding, neck circumference more
than 17" in males and 16" in females, moderate to morbid
obesity) were looked for.
Polysomnography was done based upon pulmonolo-
gist's decision to pursue testing for OSA based upon find-
i n g s  o f  s l e e p  h i s t o r y ,  p h y s i c a l  e x a m  c o n s i s t e n t  w i t h  a
possibility of sleep disordered breathing and results of
overnight oximetry. For patients undergoing polysom-
nography, the severity of sleep apnea was estimated based
on the calculated apnea-hypopnea index [9]. Treatments
and effects of therapy for chronic cough at the initial and
following visits were reviewed. Improvements in cough
were ascertained based on self-reported assessments of
cough during followup visits.
Waiver of consent for the study was obtained from the
Intermountain Office of Research. Part of the study find-
ings were presented in an abstract form during CHEST
2009, San Diego, USA [10].
Results
Patient records were reviewed from 8 different American
Board certified pulmonologists. The number of included
patients varied from 1 to 23 patients per provider, with a
mean of 9. Patient characteristics, duration of cough,
body mass index and co-morbidities are as shown in
Table 1. Out of 75 patients, 44 patients had a single diag-
nosis for chronic cough at the time of the first visit with
gastro-esophageal reflux disease (GERD) being the most
common etiology (37%) followed by upper airway cough
syndrome (UACS) (12%) and cough variant asthma
(CVA) (8%) (Table 1). One patient was diagnosed and
treated only for OSA. 31/75 (41%) patients had multiple
diagnoses for chronic cough with the combination of
GERD-UACS being the commonest followed by GERD-
CVA and UACS-CVA (Table 1). Two patients received
therapy for all three causes - UACS, GERD and CVA at
first visit.
Table 1: Patient demographics, comorbidities and etiology 
of chronic cough.
Patient characteristics N = 75
Age in years (mean ± SD) 57 (± 14)
Female:Male ratio 1.5
BMI kg/m2 (mean ± SD)
Overall 32 (± 8)
Male 31 (± 5)
Female 33 (± 9)
Duration of cough in weeks 
(mean ± SD)
Overall 127 (± 274)
Male 55 (± 101)
Female 175 (± 337)
Comorbidities
Hypertension 25 (33%)
Diabetes mellitus 9 (12%)
Rheumatoid arthritis 1 (1%)
Known sleep apnea 13 (17%)
Coronary artery disease 1 (1%)
ACE-I therapy 10 (13%)
Single diagnoses for cough 43/75 (57%)
GERD 28 (37%)
UACS 9 (12%)
CVA 6 (8%)
Multiple diagnoses for cough 31/75 (41%)
GERD & UACS 23 (31%)
UACS & CVA 2 (3%)
GERD & CVA 4 (5%)
UACS, GERD & CVA 2 (2%)
Abbreviations: BMI - Body mass index, ACE-I - Angiotensin 
converting enzyme inhibitors.Sundar et al. Cough 2010, 6:2
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GERD was the commonest etiology for chronic cough
(irrespective of whether diagnosis was made as part of
single or multiple etiologies) followed by UACS and then
CVA. Proportion of patients with diagnoses of GERD,
UACS and CVA (single or multiple diagnoses of cough)
were 76%, 48% and 19% respectively. In 39% of patients,
there was a history of an upper or lower respiratory tract
infection at the onset of cough although this occurred
more than 8 weeks before the patient presented to the
pulmonary clinic. 5/75 patients had stoppage of angio-
tensin-converting enzyme inhibitors as a part of their
management of chronic cough.
The investigative workup for these patients is detailed
in Table 2. Two patients underwent methacholine chal-
lenge testing with one test demonstrating bronchial
hyperreactivity. All chest CT scans performed were nor-
mal. Sinus radiographs or CT scans were ordered in 10
patients with 3 showing evidence of sinusitis (Table 2).
ENT referrals were made in 4 patients. Two patients
underwent upper gastrointestinal endoscopy with one
undergoing 24 hour pH monitoring (Table 2).
67 patients in this study came as referrals from primary
care providers (5 patients were self-referred to clinic).
Two patients were referred from an ENT specialist and 1
from a gastroenterologist. Most if not all had been tried
on multiple previous therapies including those for GERD,
CVA and UACS. Despite this all patients were tried on
therapeutic interventions based on the clinical impres-
sion of the treating pulmonologist. No patient underwent
additional workup beyond chest X-rays and PFTs at the
time of the initial visit. Initial and subsequent therapies
were guided entirely by pulmonologist's empiric diagno-
sis of etiology of cough and therapeutic responses to ren-
dered therapies. Although this approach broadly followed
the outlines of the pathway for the management of
chronic cough in the ACCP guidelines, there were varia-
tions from this pathway based on intention to pursue
therapy based upon the perceived etiology. Percentage of
improvement with different initial therapies for GERD,
UACS and CVA was 82%, 56%, 83% respectively. In the
groups with multiple diagnoses, initial therapies were
successful in 78% of the UACS-GERD group, 50% of the
GERD-CVA group and 100% of the UACS-GERD-CVA
and UACS-CVA groups. Inhaled steroid therapy was
done in 19% of patients and oral steroids were given in 4%
of patients. 12 patients received empiric macrolide ther-
apy in conjunction with other therapies that improved
cough in 7 patients. Significant variations were noted in
the proportion of patients treated for GERD, UACS and
CVA between different providers.
A sleep history was elicited in 55% of the patients
(Table 2). This included history of duration of sleep, sleep
quality, daytime somnolescence, history of snoring and
apneic spells. The decision to elicit history pertinent to
the diagnosis of OSA varied amongst providers. A sleep
history was consistently elicited in pulmonologists who
were American Board certified in Sleep Medicine as well.
Similarly details regarding historical aspects pertaining to
OSA were variable. All six patients that underwent
screening oximetry had abnormal studies. 12 patients had
previously known OSA that was inadequately treated out
of which 3 patients were not on any CPAP due to non-
compliance with previously tried CPAP therapy. 34/38
patients had abnormal polysomnographies with 33 being
diagnostic for OSA. Out of these 33 patients, 16 patients
had initiation of CPAP therapy and 11 patients had reti-
tration of their CPAP therapy. Improvement in cough was
noted in 25/27 (93%) patients that had initiation of new
CPAP therapy or re-titration to optimal CPAP pressures.
CPAP therapy was initiated or re-titrated in 18/27 of
patients following the first visit, 6/27 following the sec-
ond visit and 3/27 of patients thereafter. Patient charac-
teristics, duration of cough, concomitant diagnoses, and
comorbidities of patients who were diagnosed with OSA
during evaluation for chronic cough is shown in Table 3.
Discussion
The development of guidelines for evaluation and man-
agement of chronic cough represents a major milestone
in the history of treatment of this common health prob-
lem [1]. Chronic cough accounts for 3.6% of outpatient
physician visits in the US and is the commonest com-
plaint for which medical attention is sought in the US
[11].
Current guidelines emphasize empirical management
of GERD, UACS and CVA depending on historical infor-
mation gathered in favor of these diagnoses. This is based
on the fact that a number of studies have consistently
shown that UACS, GERD and CVA account for the
majority of cases of chronic cough in the nonsmoker
[12,13]. However, there is no understanding of the patho-
biologic mechanisms by which these conditions lead to
cough. Neither is there a defined pathological substrate
that triggers cough from these conditions. This has led to
difficulty in associating the results of investigative testing
for UACS, GERD and CVA with the occurrence of cough.
In addition, the common occurrence of these predispos-
ing conditions in chronic cough patients and the lack of
reliable tests to link GERD and UACS to cough results in
therapeutic interventions being the mainstay for the diag-
nosis and resolution of the cough.
T h i s  s t u d y  e x p l o r e s  c u r r e n t  a p p r o a c h e s  t o w a r d s
chronic cough in community-based pulmonologists from
a single center in the United States. There has been a pau-
city of studies from North America on chronic cough
evaluating current diagnostic and therapeutic trends over
the last decade. This retrospective study evaluates man-
agement patterns of chronic cough over a time periodSundar et al. Cough 2010, 6:2
http://www.coughjournal.com/content/6/1/2
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overlapping and following the revised ACCP guidelines.
Not surprisingly, it continues to show the same prepon-
derance of etiologic diagnoses, namely GERD, UACS and
CVA in patients with chronic cough and a tendency
towards treating multiple etiological diagnoses during the
initial visit. As reflected in the guidelines, the etiological
diagnoses for chronic cough were based on therapeutic
interventions despite the fact that a number of these
referred patients underwent similar therapeutic interven-
tions prior to evaluation by the pulmonologist.
The extent of therapeutic testing for chronic cough has
been debated upon [14]. In this study, invasive testing for
GERD, non-acid reflux disease, abnormal esophageal
motility and testing for sputum eosinophilia was limited
or lacking. The lack of a standardized protocol for evalu-
ating sputum eosinophilia resulted in empiric therapy for
CVA in a number of patients. Testing for OSA in patients
with chronic cough has been recently recommended [5].
OSA is a common condition increasing in prevalence
with age and body mass index [15] and therefore, likely to
occur in a significant proportion of patients with chronic
cough. Even though chronic cough has been reported to
be a presenting symptom of OSA, no large prospective
studies evaluating for OSA in chronic cough patients
exist.
A major finding of this retrospective study was the
impact of concomitant evaluation and treatment for
OSA. OSA has been reported in prior case reports of
chronic cough and one case series of four patients that
resolved their cough with treatment for OSA [16,17]. In
our current study, 44% patients with chronic cough were
found to have OSA and following optimization of noctur-
nal positive pressure therapy, improvement or resolution
of cough was noted in 93% of the patients. Since therapy
for OSA was done in conjunction with other therapies for
chronic cough in all but one patient, it is not clear to what
degree the treatment for OSA had impact on the resolu-
tion of chronic cough. Despite this, the evaluation for
Periodic limb movement 
disorder
1/75 (1%)
Sleep efficiency (mean) 89%
Arousal index (mean) 17
Oxygen saturation 
(mean)
91%
Lowest oxygen 
saturation (mean)
78%
Abbreviations: OSA - Obstructive sleep apnea; AHI - Apnea 
hypopnea index.
* Bravo pH capsule with delivery system (Medtronic, Inc. 
Minneapolis, MN, USA)
Table 2: Investigative workup for etiology of chronic cough 
and sleep-apnea specific workup in patients with chronic 
cough (Continued)
Table 2: Investigative workup for etiology of chronic cough 
and sleep-apnea specific workup in patients with chronic 
cough
INVESTIGATIONS 
PERFORMED
N (%)
Pulmonary Function Tests
Spirometry 70/75 (93%)
Diffusion capacity 60/75 (80%)
Lung volumes 44/75 (59%)
Methacholine 
challenge testing
2/75 (3%)
Six-minute walk test 1/75 (1%)
Radiologic studies
Chest X-ray 54/75 (72%)
Chest CT scan 10/75 (13%)
Sinus imaging 10/75 (13%)
Endoscopic studies
Bronchoscopy 0/75
Upper GI 
endoscopy
2/75 (3%)
24 hour pH 
monitoring
1/75 (1%)
(Bravo* pH probe)
Laboratory studies 5/75 (7%)
SLEEP APNEA RELATED 
WORKUP
Sleep history obtained 41/75 (55%)
Abnormal 36/75 (48%)
Screening overnight 
oximetry
6/75 (8%)
Abnormal 6/75 (8%)
Polysomnography 38/75 (51%)
Sleep disordered 
breathing
33/75 (44%)
No OSA (AHI < 5) 4/75 (5%)
Mild OSA (AHI 6-15) 6/75 (8%)
Moderate OSA (AHI 
16-30)
6/75 (8%)
Severe OSA (AHI 
>31)
14/75 (19%)Sundar et al. Cough 2010, 6:2
http://www.coughjournal.com/content/6/1/2
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OSA in the management of chronic cough requires
important consideration given the increasing number of
reports reporting improvement in cough with treatment
of OSA. OSA can lead to or has been associated with
GERD, asthma symptoms and upper respiratory com-
plaints, all of which underlie the "pathogenic triad" lead-
ing to more than 95% of chronic cough [18]. OSA has
been shown to be associated with airway inflammation
t h a t  c a n  c o n t r i b u t e  t o  c h r o n i c  c o u g h .  I n  a  s t u d y  p e r -
formed in Sweden, the number of patients with chronic
bronchitic symptoms that were found to have sleep-dis-
ordered breathing was up to 14-29% [19]. Other studies
on patients with OSA have shown an increase in exhaled
nitric oxide values and other markers of inflammation on
sputum analyses [20,21]. A number of OSA patients can
present with bronchitic symptoms and demonstrate
bronchial hyperreactivity [22,23]. Treatment of OSA has
been shown to improve other known disorders of airway
inflammation, especially asthma and COPD. Whether
this is as a result of lessening gastroesophageal reflux that
is common with OSA [24] or due to improvement in air-
way inflammation is unknown.
As compared to other series, the diagnosis of unex-
plained cough was not given to any of our patients. A sig-
nificant incidence of unexplained cough has been noted
in different series [25]. Interestingly the profile of patients
reported for unexplained cough patients fits in with those
patients in our series that improved with specific therapy
for OSA [25]. A number of these patients start out with a
post-infectious cough that fails to resolve despite multiple
therapies directed at GERD, UACS or CVA. Whether
OSA can perpetuate cough by impairing resolution in
patients with acute bronchitis needs to be evaluated in
future studies. OSA can potentially contribute to abnor-
mal esophageal motility [26] and an enhanced cough
reflex [16], both of which have been shown to contribute
to or perpetuate cough.
This study is limited by a retrospective design, non-
standardized protocol and data collection with only 55%
of subjects being screened for OSA. Despite this a signifi-
cant number of patients were found to have OSA.
Whether this high prevalence of OSA in our chronic
cough population is due to some kind of referral bias or
due to a higher body mass index of patients is not clear.
The majority of cough patients came from primary pro-
viders who considered possible etiologies for chronic
cough as outlined in the ACCP guidelines but failed to
ascribe any relationship between the possibility of sleep-
disordered breathing and the cough. Henceforth a num-
ber of these patients were not evaluated for possibility of
sleep-disordered breathing or if they had known OSA,
the possibility of inadequately treated OSA contributing
to cough was not entertained. Although only half the
patients underwent workup for OSA and this was
expected to reduce the estimate of OSA-cough in this
population, the prevalence of OSA encountered in this
study is nevertheless very high (44%). The majority of
patients undergoing sleep apnea-related workup had an
elevated BMI that makes obesity a confounding factor in
this study purporting a link between OSA and chronic
cough. Ascribing a relationship between chronic cough
and OSA in obese subjects may also carry an overlap bias
given the common occurrence of these problems and the
linear relationship between obesity and OSA. However,
Table 3: Characteristics of patients diagnosed with OSA.
Patient characteristic N = 33
Age (mean ± SD) 57 (± 13)
Female:Male ratio 1.3
BMI kg/m2 (mean ± SD)
Overall 35 (± 7)
Male 33(± 4)
Female 36 (± 8)
Duration of cough in weeks 
(mean ± SD)
Overall 88 (± 262)
Male 23 (± 26)
Female 136 (± 341)
Comorbidities
Hypertension 12 (37%)
Diabetes mellitus 7 (21%)
Known sleep apnea 12 (37%)
Coronary artery disease 1 (3%)
ACE-I therapy 6 (18%)
Single diagnoses for cough
GERD 17/33 (52%)
UACS 2/33 (9%)
CVA 0
Multiple diagnoses for cough
GERD & UACS 10/33 (30%)
UACS & CVA 0
GERD & CVA 1/33 (3%)
UACS, GERD & CVA 2/33 (6%)
Abbreviations: OSA - Obstructive sleep apnea; BMI - Body mass 
index; ACE-I - Angiotensin converting enzyme inhibitors.Sundar et al. Cough 2010, 6:2
http://www.coughjournal.com/content/6/1/2
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the majority of obese patients in this study improved
their cough following CPAP therapy and since resolution
of cough remains the sine qua non for the diagnosis of the
etiology of cough [6], further prospective studies
researching the link between chronic cough and OSA will
have to be designed factoring in the contribution of obe-
sity. In addition, treatment for OSA can improve the con-
tribution from multiple etiologies especially GERD that
improves with the treatment of OSA. This study was also
confined to the evaluation of cough in non-smokers with-
out parenchymal lung disease. A number of recent stud-
ies have shown a high prevalence of OSA in patients with
interstitial or airway lung disease [27,28]. Treating OSA
early on in patients with parenchymal lung disease may
not only offer the potential of impacting the course of the
underlying lung disease but also the potential for amelio-
ration of the cough seen in these disorders [29].
A small number of patients in this study received mac-
rolides that were effective in 70% of those treated.
Azithromycin used for up to 12 days improved cough in
subsets of patients that also received PPIs. Macrolides
have been shown to have beneficial effects on lower
respiratory tract inflammation in a number of diseases
ranging from asthma to post-transplant bronchiolitis
[30]. Whether resolution in cough following macrolide
therapy is due to its salutary effects on lower-respiratory
tract inflammation or due to effects on sinus inflamma-
tion needs to be proven.
Conclusions
This retrospective evaluation of management of patients
with chronic cough in nonsmokers found that GERD,
UACS and CVA continued to be the commonest etiolo-
gies for chronic cough. A significant proportion of
patients had multiple etiologies for their chronic cough
and specific diagnostic workup was limited. Clinicians
primarily relied on the results of therapeutic interven-
t i o n s  i n  c a s e s  w i t h  s i n g l e  o r  m u l t i p l e  e t i o l o g i e s  f o r
chronic cough. A number of patients improved with ther-
apy of OSA that was given in conjunction with other
therapies for chronic cough. The impact of OSA in occur-
rence and perpetuation of chronic cough needs to be
evaluated prospectively in future studies of chronic
cough.
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